Paras Healthcare

Paras Healthcare

UPCOMING

IPO Date: 21 Oct - 23 Oct 2026

Listing Date: 28 Oct 2026

Price Range

₹660 to ₹693

Issue Size

1450 Cr

Min Investment

₹13,860

Min Application

21 Shares

View IPO Document

Schedule of Paras Healthcare

Issue open date

21 Oct 2026

Issue close date

23 Oct 2026

UPI mandate deadline

23 Oct 2026 (5 PM)

Allotment finalization

26 Oct 2026

Share credit

27 Oct 2026

Listing date

28 Oct 2026

Mandate end date

7 Nov 2026

Issue size

Funds Raised in the IPOAmount
Overall1450 Cr
Fresh Issue72.15 Cr
Offer for Sale1.37 Cr

Allotment DetailsNew

Allotment TimelineDetails
Allotment Date26 Oct 2026
Allotment Link{Link}

Grey Market Premium

New

Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.

DateIPO PriceGMPEst. Listing Price
16 Oct 2026Latest₹693₹97₹790(+14%)
15 Oct 2026₹693₹110₹803(+15.87%)
14 Oct 2026₹693₹0₹693(0%)

Performance Paras Healthcare

Issue PriceListing GainCurrent Market PriceP/L
₹660 to ₹693............

About Paras Healthcare

Paras Healthcare Limited is an Indian hospital operator that provides tertiary and quaternary healthcare services under the Paras Health brand. The company operates eight multi-specialty hospitals across Gurugram, Panchkula, Patna, Darbhanga, Ranchi, Udaipur, Srinagar, and Kanpur, with a total capacity of 2,211 beds as of March 31, 2026. Its principal specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and sports injury, and renal sciences. The company earns most of its revenue from inpatient services, including surgeries, hospital stays, and specialised treatments, while also generating income from outpatient consultations and pharmacy sales. It focuses primarily on North India, Bihar, and Jharkhand, with plans to expand its hospital network.

Founded in1987
Managing directorSaurabh Sood
Parent organization

Financial Overview

Strengths

5
  1. 1

    Established hospital network. Paras Healthcare operates eight hospitals with a combined capacity of 2,211 beds, providing an established presence across North India, Bihar, and Jharkhand.

  2. 2

    Specialised clinical expertise. The company focuses on six major clinical specialties—cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and sports injury, and renal sciences. Together, these specialties contributed approximately 74.70% of FY2026 revenue from operations.

  3. 3

    Improving financial performance. Revenue from operations increased from approximately ₹1,129 crore in FY2024 to ₹1,606 crore in FY2026. The company also reported a profit of approximately ₹43.8 crore in FY2026 after recording losses in FY2024 and FY2025.

  4. 4

    Improved hospital occupancy. The bed occupancy rate increased from 50.78% in FY2025 to 61.75% in FY2026. Higher occupancy can improve revenue generation from existing hospital infrastructure.

  5. 5

    Expansion opportunities. The company plans to expand its hospital network, including a proposed 300-bed hospital in Gurugram and a planned hospital in Ludhiana. Expansion could increase its capacity and reach new patient markets.

Risks

5
  1. 1

    High debt burden. The company reported borrowings of approximately ₹854 crore in FY2026. High debt can increase interest expenses and limit the funds available for hospital expansion and other business needs.

  2. 2

    Recent return to profitability. Paras Healthcare recorded losses of approximately ₹15.3 crore in FY2024 and ₹58 crore in FY2025 before returning to profit in FY2026. Sustaining profitability remains important, particularly as newer hospitals continue to develop their patient base.

  3. 3

    Geographic concentration. The company's operations are concentrated in North India, Bihar, and Jharkhand. Regional competition, changes in local demand, or economic conditions could affect its performance.

  4. 4

    Dependence on specialised clinical services. The six core clinical specialties contributed 74.70% of FY2026 revenue. Changes in patient volumes, doctor availability, treatment demand, or competition in these specialties could affect revenue.

  5. 5

    Hospital expansion and operating risks. Opening new hospitals requires substantial investment in infrastructure, medical equipment, staffing, and regulatory compliance. New hospitals may take time to achieve sufficient occupancy and profitability. The company's two newer hospitals in Srinagar and Kanpur contributed to its losses in FY2024 and FY2025 during their ramp-up period.

Subscription Figures

CategorySubscription (No. of times)
Qualified Institutional Buyers (QIBs)N/A
Non-Institutional Investors (NIIs)N/A
Retail Individual Investors (RIIs)N/A
EmployeeN/A
TotalN/A